Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001221508-12-000003
Filing Date
2012-02-14
Accepted
2012-02-14 15:39:21
Documents
11
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 MLPH FORM 10 Q 2011-12-31 mlph-12312011.htm 10-Q 537307
2 MLPH EX-31.1 ex311a_dec312011.htm EX-31 7815
3 MLPH EX-32 ex32_dec312011.htm EX-32 3920
4 MLPH EX-31.1A ex312a_dec312011.htm EX-31 7723
10 MLPH BOX box.gif GRAPHIC 104
11 MLPH BOX 2 tickedbox.gif GRAPHIC 897
  Complete submission text file 0001221508-12-000003.txt   2299273

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE - MLPH 2011-12-31 mlph-20111231.xml EX-101.INS 400332
6 XBRL SCHEMA FILE - MLPH 2011-12-31 mlph-20111231.xsd EX-101.SCH 11090
7 XBRL DEFINITION FILE - MLPH 2011-12-31 mlph-20111231_def.xml EX-101.DEF 15757
8 XBRL LABEL FILE - MLPH 2011-12-31 mlph-20111231_lab.xml EX-101.LAB 85794
9 XBRL PRESENTATION FILE - MLPH 2011-12-31 mlph-20111231_pre.xml EX-101.PRE 62452
Mailing Address SUITE 1023 8721 SANTA MONICA BOULEVARD LOS ANGELES CA 900694507
Business Address DRUG DISCOVERY RESEARCH CENTRE 284 OXFORD STREET, LEEDERVILLE 6007 PERTH, WESTERN AUSTRALIA C3 00000 011-61-8-9443-3011
Molecular Pharmacology (USA) Ltd. (Filer) CIK: 0001191357 (see all company filings)

EIN.: 710900799 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-50156 | Film No.: 12608988
SIC: 2834 Pharmaceutical Preparations